The global NGS-based RNA-seq Market was valued at USD 0.89 billion in 2016 and is projected to reach USD 4.65billion by 2025, growing at a CAGR of 20.17% from 2017 to 2025.
Next-generation sequencing (NGS), also known as high-throughput sequencing, is the term used to describe a number of different modern sequencing technologies. The increasing focus on Genetic studies and gene based therapeutic technologies is expected to boost the growth of the market in coming years.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Advantages of RNA-seq Over Microarray Technology
1.2 Technological Advancements in RNA-seq Products
1.3 Increasing Number of RNA-seq Grants
1.4 Increasing Number of Research Activities Involving RNA-seq
1.5 Rapid Growth in Precision Medicine
2. Market Restraints
2.1 Lack of Skilled Professionals
2.2 Standardization Concerns of RNA-seq in Diagnostic Testing
Market Segmentation:
1. Global NGS-based RNA-seqMarket, by End User:
1.1 Research Centers and Academic & Government Institutes
1.2 Hospitals & Clinics
1.3 Pharmaceutical & Biotechnology Companies
1.4 Other End Users
2. Global NGS-based RNA-seqMarket, by Application:
2.1 Expression Profiling Analysis
2.2 Small RNA Sequencing
2.3 De Novo Transcriptome Assembly
2.4 Variant Calling and Transcriptome Epigenetics
3. Global NGS-based RNA-seqMarket, by Technology:
3.1 Sequencing By Synthesis
3.2 Ion Semiconductor Sequencing
3.3 Single-Molecule Real-Time Sequencing
3.4 Nanopore Sequencing
4. Global NGS-based RNA-seq Market, by Product and Services:
4.1 Sample Preparation
4.1.1 Sample Preparation, By Workflow Step
4.1.1.1 Fragmentation, End Repair, and Size Selection
4.1.1.2 Library Preparation and Target Enrichment
4.1.1.3 Quality Control
4.1.2 Sample Preparation, By Method
4.1.2.1 Manual Sample Preparation
4.1.2.2 Microfluidic Sample Preparation
4.1.2.3 Robotic Liquid Handling Sample
4.1.3 Sequencing Platforms and Consumables
4.1.4 Sequencing Services
4.1.5 Data Analysis, Storage, and Management
5. Global NGS-based RNA-seq Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen N.V.
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI (Beijing Genomics Institute)
8. Oxford Nanopore Technologies, Ltd
9. Perkinelmer, Inc.
10. Eurofins Scientific
11. Gatc Biotech AG
12. Macrogen, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the NGS-based RNA-seqMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL NGS-BASED RNA-SEQ MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL NGS-BASED RNA-SEQMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL NGS-BASED RNA-SEQ MARKET, BY END USER:
5.1 Research Centers and Academic & Government Institutes
5.2 Hospitals & Clinics
5.3 Pharmaceutical & Biotechnology Companies
5.4 Other End Users
6 GLOBAL NGS-BASED RNA-SEQ MARKET, BY APPLICATION:
6.1 Expression Profiling Analysis
6.2 Small RNA Sequencing
6.3 De Novo Transcriptome Assembly
6.4 Variant Calling and Transcriptome Epigenetics
7 GLOBAL NGS-BASED RNA-SEQ MARKET, BY TECHNOLOGY:
7.1 Sequencing By Synthesis
7.2 Ion Semiconductor Sequencing
7.3 Single-Molecule Real-Time Sequencing
7.4 Nanopore Sequencing
8 GLOBAL NGS-BASED RNA-SEQ MARKET, BY PRODUCT AND SERVICES:
8.1 Sample Preparation
8.1.1 Sample Preparation, By Workflow Step
8.1.1.1 Fragmentation, End Repair, and Size Selection
8.1.1.2 Library Preparation and Target Enrichment
8.1.1.3 Quality Control
8.1.2 Sample Preparation, By Method
8.1.2.1 Manual Sample Preparation
8.1.2.2 Microfluidic Sample Preparation
8.1.2.3 Robotic Liquid Handling Sample
8.1.3 Sequencing Platforms and Consumables
8.1.4 Sequencing Services
8.1.5 Data Analysis, Storage, and Management
9 GLOBAL NGS-BASED RNA-SEQMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
10 GLOBAL NGS-BASED RNA-SEQMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies
11 COMPANY PROFILES
11.1 Illumina, Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments
11.2 Thermo Fisher Scientific Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments
11.3 Pacific Biosciences of California, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments
11.4 Qaigen N.V.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments
11.5 F. Hoffmann-La Roche AG
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments
11.6 Agilent Technologies, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments
11.7 BGI (Beijing Genomics Institute)
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments
11.8 Oxford Nanopore Technologies, Ltd
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments
11.9 Perkinelmer, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments
11.10 Eurofins Scientific
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments
11.11 Gatc Biotech AG
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments
11.12 Macrogen, Inc.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments
12 Appendix
12.1 Related Reports
The Cloud-Based Cold Chain Management Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Public Cloud Based Contact Center Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The IP-Based Mobile Games Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacturers...
The Cloud-Based Project Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...
Market Overview
The Asia Pacific Banking as a Service (BaaS) Market is set to experience substantial growth from 2024 to 2034, driven by the region's rapid digitalization, the increasing adoption of cloud-based technologies, and the growing demand for seamless financial services. As fin...
Market Overview
The Europe Banking as a Service (BaaS) Market is set to experience significant growth from 2024 to 2034, driven by the rapid digital transformation of the financial sector, the increasing adoption of embedded finance solutions, and the rising demand for seamless customer...
Market Overview
The North America Banking as a Service (BaaS) Market is poised for significant growth from 2024 to 2034, driven by the digital transformation of financial services, the increasing demand for seamless integration of banking solutions, and the expansion of fintech partners...
Market Overview
The Global Banking as a Service (BaaS) Market is anticipated to witness exponential growth from 2024 to 2034, driven by the digitization of financial services, increasing demand for seamless banking integrations, and the rising adoption of embedded finance solutions. Val...
The Evidence-Based Mental Health Apps Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, m...
The Cloud Based Relational Database Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, man...